Singapore markets close in 6 hours 39 minutes
Straits Times Index
3,301.51 +8.82 (+0.27%) Nikkei
38,177.82 -96.23 (-0.25%) Hang Seng
17,924.93 +161.90 (+0.91%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,353.27 -2,377.48 (-3.98%) CMC Crypto 200
1,257.27 -81.80 (-6.11%)
ABT May 2024 105.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:28PM EDT. Market open.
| Previous close | 1.1700 |
| Open | 0.9800 |
| Bid | 0.9600 |
| Ask | 1.0200 |
| Strike | 105.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.7000 - 1.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 8.08k |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.